GlassScriptPhysician profile
Michael J Messina
NPI 1174848394
$20,064.76
in general payments reported to CMS, 2019-2025
35 companies · $1,690 in 2025
The $1,690 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,579 · 2020: $1,079 · 2021: $2,823 · 2022: $5,402 · 2023: $4,679 · 2024: $2,813 · 2025: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,979 · Food and Beverage: $3,320 · Consulting Fee: $1,801 · Education: $82.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,978.68 |
| Food and Beverage | $3,319.53 |
| Consulting Fee | $1,800.57 |
| Education | $82.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,116.25 | 2019-2025 | Arthrex |
| Liberty Surgical INC. | $4,287.64 | 2021-2022 | |
| Stryker Corporation | $2,447.58 | 2021-2025 | Blueprint Patient Specific Instrumentation, Mako, Triathlon |
| Catalyst Orthoscience | $1,582.82 | 2023 | R1 Reverse Total Shoulder, Csr & R1 Reverse Total Shoulder Systems, Archer 3d Software |
| Zimmer Biomet Holdings, INC. | $847.44 | 2022-2025 | Persona, Sidus Stem-Free Shoulder, Rosa |
| Paladin Technology Solutions | $621.82 | 2023-2025 | |
| Smith+Nephew, INC. | $484.49 | 2019-2025 | Real Intelligence, Legion Revision, Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $328.01 | 2019-2025 | Monovisc, Orthovisc |
| Pacira Therapeutics, INC. | $200.52 | 2019-2021 | |
| Fx Shoulder Solutions, INC | $160.52 | 2019-2024 | |
| Nevro Corp. | $110.31 | 2022-2023 | Senza |
| Vericel Corporation | $107.67 | 2022-2024 | Maci |
| Bioventus LLC | $68.39 | 2024-2025 | Xcell, Durolane |
| Dynasplint Systems INC. | $62.33 | 2024 | Dynasplint |
| Heraeus Medical, LLC. | $58.04 | 2020-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $57.77 | 2025 | |
| Ossur Americas, INC. | $50.08 | 2025 | Unloader One X |
| Electronic Waveform Lab, INC. | $45.38 | 2019-2021 | |
| Eclipse Technology Solutions INC. | $41.81 | 2023 | |
| Ferring Pharmaceuticals INC. | $40.46 | 2024-2025 | Euflexxa |
| Davol INC. | $37.97 | 2021-2024 | Arista Ah Flexitip |
| Sanofi-Aventis U.S. LLC | $36.33 | 2019 | |
| Avanos Medical | $30.04 | 2019-2021 | |
| Nalu Medical, INC. | $26.26 | 2025 | Nalu Neurostimulation System |
| Orthofix Medical, INC. | $26.05 | 2021-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $25.19 | 2020-2021 | |
| Fidia Pharma USA INC. | $23.38 | 2023 | Hymovis |
| Heron Therapeutics, INC. | $22.54 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $21.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.66 | 2025 | Iovera, Zilretta |
| Sanara Medtech INC. | $18.38 | 2023 | Celleraterx |
| Pfizer INC. | $17.49 | 2025 | |
| Medical Device Business Services, INC. | $16.51 | 2024 | Inhance |
| Kowa Pharmaceuticals America, INC. | $12.82 | 2022 | |
| Ermi LLC | $10.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Messina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.